Issues in outcomes research: an overview of randomization techniques for clinical trials.
Minsoo Kang, Brian G Ragan, Jae-Hyeon Park
https://pubmed.ncbi.nlm.nih.gov/18345348/Actively Recruiting
Phase Not Applicable
Age: 18Years +
MALE
ID06769997
Comparing Optilume BPH Catheter System and Rezum Water Vapor Therapy for Treating Benign Prostatic Hyperplasia in Men
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2025-07-17
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Lower urinary symptoms LUTS commonly affect older men and tend to worsen with age due to benign prostatic hyperplasia BPH, which can cause bladder outlet obstruction and impact quality of life. This research aims to compare two innovative treatments, the Optilume BPH Catheter System and Rezum Water Vapor Therapy, in relieving symptoms and improving function in men with BPH. The study is a prospective, randomized, single-center clinical trial funded by Laborie Urotronic and led by the Centre hospitalier de lUniversit de Montral.
CONDITIONS
Brief Title
Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia
Research Team
N
Naeem Bhojani, MD
A
Abbas Guennoun, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here